Twist Bioscience Partners with Vanderbilt University Medical Center to Supply Critical Products and Identify Antibody Therapeutics for COVID-19

/in , , , , , , /by

SOUTH SAN FRANCISCO, Calif.– Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a collaboration with Vanderbilt University Medical Center (VUMC) to supply synthetic genes and antibodies for the development of therapies for COVID-19. In addition, Twist Biopharma, a division […]

Read more →

Sartorius Supports the Development of the First Vaccine Candidate Against the Novel Coronavirus to Enter Clinical Trials

/in , , , , /by

SHANGHAI, China,– Sartorius, a leading international partner of life science research and the biopharmaceutical industry, has supported CanSino Biologics Inc. (“CanSinoBIO”) and Maj. Gen. Chen Wei’s team at the Institute of Bioengineering at the Academy of Military Medical Sciences (“Institute of Bioengineering”) in China in their development of the first vaccine candidate against the novel coronavirus […]

Read more →

Avectas and Vycellix Announce Collaboration to Advance Next-Generation Solutions for the Optimized Manufacture of Cell & Gene Therapies

/in , , , , , , /by

DUBLIN and TAMPA, Florida, — Avectas, a cell engineering technology business and Vycellix, Inc. an immuno-discovery cell & gene therapy company, today announced that the companies have entered into a collaboration agreement to develop proprietary approaches for cell-based immunotherapeutic products. The companies will collaborate on the delivery of Vycellix’s novel RNA immunomodulator VY-M using Avectas’ […]

Read more →

IsoPlexis and Institute for Systems Biology partner to uncover the functional immune mechanisms behind COVID-19 response

/in , , , /by

IsoPlexis teams with industry leaders to accelerate the development of improved detection methods that inform understanding and treatment of COVID-19 BRANFORD, Conn. and SEATTLE — IsoPlexis, the leader in functional cellular proteomics, and the Institute for Systems Biology (ISB) announced a partnership mapping functional immune responses at the single cell level to study COVID-19. Uncovering functional immune responses using […]

Read more →

PathSensors, Inc. Announced the Development of a SARS-CoV-2 Biosensor

/in , , /by

BALTIMORE, MD  – PathSensors Inc, a Baltimore biotechnology company, announced today that they are developing a CANARY biosensor to detect the Novel SARS Coronavirus (SARS-CoV-2), the causal agent for the coronavirus disease COVID–19. The biosensor will be available for research purposes in May 2020 and validation data on the new SARS-CoV-2 product will be available […]

Read more →